05/28/2024
5:03 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024
5:35 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024
5:01 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024
5:07 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024
5:03 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024
5:02 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
04/10/2024
5:51 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024
7:03 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/21/2024
8:20 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/21/2024
5:01 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2024
5:33 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
6:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/21/2024
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2024
4:00 PM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 424B5 | |
02/06/2024
4:05 PM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/16/2024
11:15 PM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form EFFECT | |
01/12/2024
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/05/2024
5:09 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/04/2024
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/04/2024
5:01 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023
3:45 PM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
12/20/2023
3:30 PM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/18/2023
10:40 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2023
5:01 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/27/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/07/2023
5:01 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/03/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/27/2023
5:01 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/19/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/10/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/05/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/22/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/14/2023
5:27 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/14/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
[Urgent!] Generational Wealth Gameplan (Ad) A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide |
08/29/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/10/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/07/2023
5:01 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/16/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2023
5:01 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/08/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/07/2023
5:00 AM | Innate Pharma SA (Filer)
Innate Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
